[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Thermo Fisher CDR (Cad Hedged) (TMO.TO)

Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Thermo Fisher CDR (Cad Hedged) 168 Third Avenue Waltham MA 02451 USA

https://www.thermofisher.com P: 781-622-1000 F: 781-622-1207

Sector:

Medical

INDUSTRY GROUPING:

TSX Diagnostics & Research

Description:

Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).

Key Statistics

Overview:

Market Capitalization, $K 238,634,888
Shares Outstanding, K 13,645,228
% of Institutional Shareholders 0.00%

Financials:

Annual Sales, $ 44,557 M
Annual Net Income, $ 6,704 M
Last Quarter Sales, $ 12,215 M
Last Quarter Net Income, $ 1,964 M

Growth:

1-Year Return 7.47%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 6.70%
5-Year Earnings Growth 2.14%

Per-Share Information:

Most Recent Earnings 0.12 on 04/23/26
Next Earnings Date N/A
Earnings Per Share ttm 0.50
EPS Growth vs. Prev Qtr 22.01%
EPS Growth vs. Prev Year 0.07%
Annual Dividend & Yield (Paid) 0.05 (0.38%)
Annual Dividend & Yield (Fwd) 0.07 (0.38%)
Most Recent Dividend 0.017 on 03/13/26
Next Ex-Dividends Date 03/13/26
Dividend Payable Date 04/22/26
Dividend Payout Ratio 9.42%

TMO.TO Ratios

Ratio
Price/Earnings ttm 24.85
Price/Earnings forward 18.28
Price/Earnings to Growth 1.50
Return-on-Equity % 13.02%
Return-on-Assets % 6.46%
Profit Margin % 15.05%
Debt/Equity 0.67
Price/Sales 3.76
Price/Book 3.23
Book Value/Share 5.21

TMO.TO Dividends

Date Value
03/13/26 $0.0171
12/15/25 $0.0156
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.